Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis

od Miller David H, Edan Gilles, Freedman Mark S, Barkhof Frederik, Polman Chris H, Pohl Christoph, Nielsen Jessica M, Bauer Lars, Sandbrink Rupert, Kappos Ludwig, Uitdehaag Bernard MJ
Wydane 2011-02-01

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

od Nielsen, Jessica M, Pohl, Christoph, Polman, Chris H, Barkhof, Frederik, Freedman, Mark S, Edan, Gilles, Miller, David H, Bauer, Lars, Sandbrink, Rupert, Kappos, Ludwig, Uitdehaag, Bernard MJ
Wydane 2009

Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis

od Nielsen, Jessica M, Pohl, Christoph, Polman, Chris H, Barkhof, Frederik, Freedman, Mark S, Edan, Gilles, Miller, David H, Bauer, Lars, Sandbrink, Rupert, Kappos, Ludwig, Uitdehaag, Bernard MJ
Wydane 2011

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT

od Munger, Kassandra L., Fitzgerald, Kathryn C., Freedman, Mark S., Hartung, Hans-Peter, Miller, David H., Montalbán, Xavier, Edan, Gilles, Barkhof, Frederik, Suarez, Gustavo, Radue, Ernst-Wilhelm, Sandbrink, Rupert, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto
Wydane w Neurology (2015)

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

od Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria
Wydane w Neurology (2016)

The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial

od Joussen, Antonia M., Wolf, Sebastian, Kaiser, Peter K., Boyer, David, Schmelter, Thomas, Sandbrink, Rupert, Zeitz, Oliver, Deeg, Gesa, Richter, Annett, Zimmermann, Torsten, Hoechel, Joachim, Buetehorn, Ulf, Schmitt, Walter, Stemper, Brigitte, Boettger, Michael K.
Wydane w Br J Clin Pharmacol (2018)

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

od Penner, Iris-Katharina, Stemper, Brigitte, Calabrese, Pasquale, Freedman, Mark S, Polman, Chris H, Edan, Gilles, Hartung, Hans-Peter, Miller, David H, Montalbán, Xavier, Barkhof, Frederik, Pleimes, Dirk, Lanius, Vivian, Pohl, Christoph, Kappos, Ludwig, Sandbrink, Rupert
Wydane 2012

Molecular mechanism underlying the impact of vitamin D on disease activity of MS

od Munger, Kassandra L, Köchert, Karl, Simon, Kelly C, Kappos, Ludwig, Polman, Chris H, Freedman, Mark S, Hartung, Hans P, Miller, David H, Montalbán, Xavier, Edan, Gilles, Barkhof, Frederik, Pleimes, Dirk, Sandbrink, Rupert, Ascherio, Alberto, Pohl, Christoph
Wydane 2014

Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis

od Hartung, Hans-Peter, Steinman, Lawrence, Goodin, Douglas S., Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, O’Connor, Paul, Jeffery, Douglas R., Kappos, Ludwig, Axtell, Robert, Knappertz, Volker, Bogumil, Timon, Schwenke, Susanne, Croze, Ed, Sandbrink, Rupert, Pohl, Christopher
Wydane w JAMA Neurol (2013)

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

od Hartung, Hans-Peter, Kappos, Ludwig, Goodin, Douglas S., O’Connor, Paul, Filippi, Massimo, Arnason, Barry, Comi, Giancarlo, Cook, Stuart, Jeffery, Douglas, Petkau, John, White, Richard, Bogumil, Timon, Beckmann, Karola, Stemper, Brigitte, Suarez, Gustavo, Sandbrink, Rupert, Pohl, Christoph
Wydane w J Neurol (2015)

Subtraction MR Images in a Multiple Sclerosis Multicenter Clinical Trial Setting

od Moraal, Bastiaan, Meier, Dominik S., Poppe, Peter A., Geurts, Jeroen J. G., Vrenken, Hugo, Jonker, William M. A., Knol, Dirk L., van Schijndel, Ronald A., Pouwels, Petra J. W., Pohl, Christoph, Bauer, Lars, Sandbrink, Rupert, Guttmann, Charles R. G., Barkhof, Frederik
Wydane 2009

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies

od Hartung, Hans-Peter, Kieseier, Bernd, Goodin, Douglas S, Arnason, Barry GW, Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Jeffery, Douglas R, Kappos, Ludwig, Bogumil, Timon, Stemper, Brigitte, Sandbrink, Rupert, Nakada, Yukiko, Nakajima, Haruhiko, Schwenke, Susanne, Lehr, Stephan, Heubach, Jürgen, Pohl, Christoph, Reischl, Joachim
Wydane 2012

Vitamin D as an early predictor of multiple sclerosis activity and progression

od Ascherio, Alberto, Munger, Kassandra L., White, Rick, Köchert, Karl, Simon, Kelly Claire, Polman, Chris H., Freedman, Mark S., Hartung, Hans-Peter, Miller, David H., Montalbán, Xavier, Edan, Gilles, Barkhof, Frederik, Pleimes, Dirk, Radü, Ernst-Wilhelm, Sandbrink, Rupert, Kappos, Ludwig, Pohl, Christoph
Wydane 2014

Integrating genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility

od De Jager, Philip L., Chibnik, Lori B., Cui, Jing, Reischl, Joachim, Lehr, Stephan, Simon, K. Claire, Aubin, Cristin, Bauer, David, Heubach, Jürgen F., Sandbrink, Rupert, Tyblova, Michaela, Lelkova, Petra, Havrdova, Eva, Pohl, Christoph, Horakova, Dana, Ascherio, Alberto, Hafler, David A., Karlson, Elizabeth W.
Wydane 2009

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry

od Bendfeldt, Kerstin, Taschler, Bernd, Gaetano, Laura, Madoerin, Philip, Kuster, Pascal, Mueller-Lenke, Nicole, Amann, Michael, Vrenken, Hugo, Wottschel, Viktor, Barkhof, Frederik, Borgwardt, Stefan, Klöppel, Stefan, Wicklein, Eva-Maria, Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Pohl, Christoph, Sandbrink, Rupert, Sprenger, Till, Radue, Ernst-Wilhelm, Wuerfel, Jens, Nichols, Thomas E.
Wydane w Brain Imaging Behav (2018)